JP2010540446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540446A5 JP2010540446A5 JP2010525937A JP2010525937A JP2010540446A5 JP 2010540446 A5 JP2010540446 A5 JP 2010540446A5 JP 2010525937 A JP2010525937 A JP 2010525937A JP 2010525937 A JP2010525937 A JP 2010525937A JP 2010540446 A5 JP2010540446 A5 JP 2010540446A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- decrease
- composition according
- caused
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 18
- 230000035945 sensitivity Effects 0.000 claims 10
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 7
- 108010036949 Cyclosporine Proteins 0.000 claims 7
- 229960001265 ciclosporin Drugs 0.000 claims 6
- 229930105110 Cyclosporin A Natural products 0.000 claims 5
- 208000036142 Viral infection Diseases 0.000 claims 5
- 230000009385 viral infection Effects 0.000 claims 5
- 238000001356 surgical procedure Methods 0.000 claims 3
- 108010013381 Porins Proteins 0.000 claims 2
- 229930182912 cyclosporin Natural products 0.000 claims 2
- 102000007739 porin activity proteins Human genes 0.000 claims 2
- 206010061788 Corneal infection Diseases 0.000 claims 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 210000004087 cornea Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/858,200 US20080146497A1 (en) | 2006-07-25 | 2007-09-20 | Cyclosporin Compositions |
| PCT/US2008/076756 WO2009099467A2 (en) | 2007-09-20 | 2008-09-18 | Cyclosporin compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540446A JP2010540446A (ja) | 2010-12-24 |
| JP2010540446A5 true JP2010540446A5 (enExample) | 2011-11-10 |
Family
ID=39528114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525937A Pending JP2010540446A (ja) | 2007-09-20 | 2008-09-18 | シクロスポリン組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080146497A1 (enExample) |
| EP (1) | EP2190407B1 (enExample) |
| JP (1) | JP2010540446A (enExample) |
| KR (1) | KR20100091946A (enExample) |
| CN (1) | CN101835463A (enExample) |
| AU (1) | AU2008349774A1 (enExample) |
| BR (1) | BRPI0816995A2 (enExample) |
| CA (1) | CA2700182A1 (enExample) |
| IL (1) | IL204614A0 (enExample) |
| MX (1) | MX2010003045A (enExample) |
| RU (1) | RU2010112472A (enExample) |
| WO (1) | WO2009099467A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| JP5668476B2 (ja) | 2007-10-08 | 2015-02-12 | オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物 |
| US20100279951A1 (en) * | 2009-05-01 | 2010-11-04 | Aileen Morgan | Method of treating allergic conjunctivitis with cyclosporin compositions |
| WO2010144194A1 (en) * | 2009-06-09 | 2010-12-16 | Lux Biosciences, Inc. | Topical drug delivery systems for ophthalmic use |
| BR112014014678A2 (pt) * | 2011-12-16 | 2017-06-13 | Allergan Inc | composições oftálmicas compreendendo copolímeros de enxertia de polivinil caprolactama-acetato de polivinila-polietileno glicol |
| FR2988297B1 (fr) * | 2012-03-22 | 2014-03-28 | Thea Lab | Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur |
| JP2015519368A (ja) | 2012-06-01 | 2015-07-09 | アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | シクロスポリンａ類似体 |
| CA2955037A1 (en) | 2014-07-18 | 2016-01-21 | Allergan, Inc. | Suspension compositions of cyclosporin a for subconjunctival and periocular injection |
| KR101587412B1 (ko) * | 2014-10-17 | 2016-01-21 | 주식회사 휴온스 | 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물 |
| WO2016112321A1 (en) | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| RU2762767C1 (ru) * | 2020-09-15 | 2021-12-22 | Федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Министерства здравоохранения Российской Федерации | Способ определения тактильной чувствительности роговицы |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2577049B2 (ja) * | 1987-06-04 | 1997-01-29 | 三共株式会社 | シクロスポリン製剤 |
| KR920003601B1 (ko) * | 1987-09-03 | 1992-05-04 | 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 | 점안 싸이클로스포린(cyclosporin)의 조성물 |
| HK1004520A1 (en) * | 1992-05-13 | 1998-11-27 | Novartis Ag | Ophthalmic compositions containing a cyclosporin |
| KR20030023700A (ko) * | 2000-07-14 | 2003-03-19 | 알러간, 인코포레이티드 | 치료활성 성분을 함유하고 용해도가 증강된 조성물 |
| WO2007011880A2 (en) * | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
| US7501393B2 (en) * | 2005-07-27 | 2009-03-10 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| AU2006311577B2 (en) * | 2005-11-09 | 2013-02-07 | Zalicus Inc. | Methods, compositions, and kits for the treatment of medical conditions |
-
2007
- 2007-09-20 US US11/858,200 patent/US20080146497A1/en not_active Abandoned
-
2008
- 2008-09-18 WO PCT/US2008/076756 patent/WO2009099467A2/en not_active Ceased
- 2008-09-18 AU AU2008349774A patent/AU2008349774A1/en not_active Abandoned
- 2008-09-18 CA CA2700182A patent/CA2700182A1/en not_active Abandoned
- 2008-09-18 KR KR1020107008509A patent/KR20100091946A/ko not_active Withdrawn
- 2008-09-18 JP JP2010525937A patent/JP2010540446A/ja active Pending
- 2008-09-18 MX MX2010003045A patent/MX2010003045A/es not_active Application Discontinuation
- 2008-09-18 BR BRPI0816995 patent/BRPI0816995A2/pt not_active IP Right Cessation
- 2008-09-18 EP EP08872212.9A patent/EP2190407B1/en not_active Not-in-force
- 2008-09-18 CN CN200880113223A patent/CN101835463A/zh active Pending
- 2008-09-18 RU RU2010112472/15A patent/RU2010112472A/ru not_active Application Discontinuation
-
2010
- 2010-03-18 IL IL204614A patent/IL204614A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010540446A5 (enExample) | ||
| Zhu et al. | Broad-spectrum antiviral agents | |
| RU2010112472A (ru) | Композиции циклоспорина | |
| JP2020502197A5 (enExample) | ||
| JP2014516954A5 (enExample) | ||
| RU2010141542A (ru) | Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций | |
| RU2012140704A (ru) | Способ профилактики и/или лечения фиброза и/или помутнения роговицы (варианты), способ получения фармацевтической композиции для профилактики и/или лечения фиброза и/или помутнения роговицы и глазная фармацевтическая композиция | |
| JP2013542224A5 (enExample) | ||
| CN102066402B (zh) | 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物 | |
| KR20090008291A (ko) | 눈꺼풀, 눈 표면, 피부 또는 귀에 감염 또는 감염성 정착 치료를 위한 조성물 및 방법 | |
| RU2017118405A (ru) | Новое лечение роговицы с применением ламинина | |
| WO2008136034A3 (en) | Ophthalmic compositions for the treatment of ocular hypertension and glaucoma | |
| KR20180037185A (ko) | 광범위의 항감염성 펩티드 | |
| JP2013537551A5 (enExample) | ||
| Moerdyk-Schauwecker et al. | Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27 | |
| JP2018536638A5 (enExample) | ||
| CN104147162B (zh) | 风湿止痛液及其使用方法 | |
| JP2015132804A (ja) | コンタクトレンズ装着用液剤およびそれを用いたコンタクトレンズの屈折率向上方法 | |
| CN101491245A (zh) | 一种含林蛙抗菌肽的消毒制剂及其制备方法和应用 | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| KR20110104367A (ko) | 무보존제 안과용 조성물 | |
| CA3145062C (en) | COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF EYE INFECTIONS WITH FILOCICLOVIR | |
| Daelemans et al. | Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle | |
| JP2019525923A5 (enExample) | ||
| Zarei-Ghanavati et al. | Acute Klebsiella pneumoniae interface keratitis after deep anterior lamellar keratoplasty. |